D J Allingham-Hawkins

Summary

Affiliation: North York General Hospital
Country: Canada

Publications

  1. ncbi request reprint Impact of carrier status determination for Duchenne/Becker muscular dystrophy by computer-assisted laser densitometry
    D J Allingham-Hawkins
    Department of Genetics, The Hospital for Sick Children, Toronto, Ontario, Canada
    Am J Med Genet 75:171-5. 1998
  2. pmc Fragile X premutation is a significant risk factor for premature ovarian failure: the International Collaborative POF in Fragile X study--preliminary data
    D J Allingham-Hawkins
    Am J Med Genet 83:322-5. 1999
  3. pmc FRAXE expansion is not a common etiological factor among developmentally delayed males
    D J Allingham-Hawkins
    Department of Genetics, The Hospital for Sick Children, Toronto, Ontario, Canada
    Am J Hum Genet 57:72-6. 1995

Collaborators

Detail Information

Publications3

  1. ncbi request reprint Impact of carrier status determination for Duchenne/Becker muscular dystrophy by computer-assisted laser densitometry
    D J Allingham-Hawkins
    Department of Genetics, The Hospital for Sick Children, Toronto, Ontario, Canada
    Am J Med Genet 75:171-5. 1998
    ..Subsequent analysis of more than 800 women from more than 400 D/BMD families has shown that a highly accurate carrier risk can be given in more than 90% of cases...
  2. pmc Fragile X premutation is a significant risk factor for premature ovarian failure: the International Collaborative POF in Fragile X study--preliminary data
    D J Allingham-Hawkins
    Am J Med Genet 83:322-5. 1999
    ..4%) of the controls. Based on these preliminary data, there is a significant association between fragile X premutation carrier status and premature menopause...
  3. pmc FRAXE expansion is not a common etiological factor among developmentally delayed males
    D J Allingham-Hawkins
    Department of Genetics, The Hospital for Sick Children, Toronto, Ontario, Canada
    Am J Hum Genet 57:72-6. 1995
    ..The data support the hypothesis that FRAXE is either very rare or a benign fragile site that is not associated with any clinical phenotype, similar to the FRAXF and FRA16A sites...